FDA — authorised 15 November 2019
- Application: BLA761128
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Local brand name: ADAKVEO
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 ADAKVEO in United States
FDA authorised ADAKVEO on 15 November 2019
Marketing authorisations
FDA
- Status: approved
ADAKVEO in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is ADAKVEO approved in United States?
Yes. FDA authorised it on 15 November 2019; FDA has authorised it.
Who is the marketing authorisation holder for ADAKVEO in United States?
NOVARTIS PHARMS CORP holds the US marketing authorisation.